Cargando…
Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action
Purpose: The present work endeavors to report a systematic approach of developing the lipidic self-nanoemulsifying formulation of olmesartan medoxomil (OMT) on the principles of Quality by Design (QbD). Methods: For preparing the self-nanoemulsifying formulation, a mixture of oil, surfactant and cos...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335990/ https://www.ncbi.nlm.nih.gov/pubmed/32665896 http://dx.doi.org/10.34172/apb.2020.046 |
_version_ | 1783554232772722688 |
---|---|
author | Arun, Jagdish Kumar Vodeti, Rajeshwar Shrivastava, Birendra Bakshi, Vasudha |
author_facet | Arun, Jagdish Kumar Vodeti, Rajeshwar Shrivastava, Birendra Bakshi, Vasudha |
author_sort | Arun, Jagdish Kumar |
collection | PubMed |
description | Purpose: The present work endeavors to report a systematic approach of developing the lipidic self-nanoemulsifying formulation of olmesartan medoxomil (OMT) on the principles of Quality by Design (QbD). Methods: For preparing the self-nanoemulsifying formulation, a mixture of oil, surfactant and cosurfactant were used as vehicles. The excipients were selected after screening by solubility as well as pseudoternary phase titration studies. Mixture design was adopted for systematic optimization of the composition of nanolipidic formulations, which were evaluated for smaller globule size, stable zeta potential and lower values of polydispersity index. The optimized liquid self-nanoemulsifying formulation was identified using numerical and graphical optimization techniques, followed by validation of the experimental model. Solidification of self-nanoemulsifying formulation was carried out using porous carriers, and then optimized on the basis of oil adsorption potential, powder flow property and drug release performance. Pharmacokinetic study was performed in male Wistar rats for evaluating the drug absorption parameters. All the experimental data obtained were subjected to statistical analysis using oneway ANOVA followed by post hoc analysis using Student’s t test. Results: The optimized liquid self-nanoemulsifying formulation showed globule size <100 nm, emulsification efficiency <5 minutes andin vitro drug release >85% within in 30 minutes. Further, the solid SNEDDS formulation was effectively formulated using Neusilin US2 with maximum oil adsorption capacity and good micromeritic properties. Pharmacokinetic evaluation indicated 4 to 5-folds increase (P <0.05) in the values of C(max), AUC, and reduction in T(max) from the nanoformulations vis-à-vis the marketed formulation. Conclusion: Overall, the developed nanolipidic formulation of olmesartan indicated superior efficacy in augmenting the drug dissolution and absorption performance. |
format | Online Article Text |
id | pubmed-7335990 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Tabriz University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-73359902020-07-13 Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action Arun, Jagdish Kumar Vodeti, Rajeshwar Shrivastava, Birendra Bakshi, Vasudha Adv Pharm Bull Research Article Purpose: The present work endeavors to report a systematic approach of developing the lipidic self-nanoemulsifying formulation of olmesartan medoxomil (OMT) on the principles of Quality by Design (QbD). Methods: For preparing the self-nanoemulsifying formulation, a mixture of oil, surfactant and cosurfactant were used as vehicles. The excipients were selected after screening by solubility as well as pseudoternary phase titration studies. Mixture design was adopted for systematic optimization of the composition of nanolipidic formulations, which were evaluated for smaller globule size, stable zeta potential and lower values of polydispersity index. The optimized liquid self-nanoemulsifying formulation was identified using numerical and graphical optimization techniques, followed by validation of the experimental model. Solidification of self-nanoemulsifying formulation was carried out using porous carriers, and then optimized on the basis of oil adsorption potential, powder flow property and drug release performance. Pharmacokinetic study was performed in male Wistar rats for evaluating the drug absorption parameters. All the experimental data obtained were subjected to statistical analysis using oneway ANOVA followed by post hoc analysis using Student’s t test. Results: The optimized liquid self-nanoemulsifying formulation showed globule size <100 nm, emulsification efficiency <5 minutes andin vitro drug release >85% within in 30 minutes. Further, the solid SNEDDS formulation was effectively formulated using Neusilin US2 with maximum oil adsorption capacity and good micromeritic properties. Pharmacokinetic evaluation indicated 4 to 5-folds increase (P <0.05) in the values of C(max), AUC, and reduction in T(max) from the nanoformulations vis-à-vis the marketed formulation. Conclusion: Overall, the developed nanolipidic formulation of olmesartan indicated superior efficacy in augmenting the drug dissolution and absorption performance. Tabriz University of Medical Sciences 2020-07 2020-05-11 /pmc/articles/PMC7335990/ /pubmed/32665896 http://dx.doi.org/10.34172/apb.2020.046 Text en © 2020 The Authors. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, as long as the original authors and source are cited. No permission is required from the authors or the publishers. |
spellingShingle | Research Article Arun, Jagdish Kumar Vodeti, Rajeshwar Shrivastava, Birendra Bakshi, Vasudha Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action |
title | Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action |
title_full | Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action |
title_fullStr | Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action |
title_full_unstemmed | Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action |
title_short | Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action |
title_sort | integrated quality by design approach for developing nanolipidic drug delivery systems of olmesartan medoxomil with enhanced antihypertensive action |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335990/ https://www.ncbi.nlm.nih.gov/pubmed/32665896 http://dx.doi.org/10.34172/apb.2020.046 |
work_keys_str_mv | AT arunjagdishkumar integratedqualitybydesignapproachfordevelopingnanolipidicdrugdeliverysystemsofolmesartanmedoxomilwithenhancedantihypertensiveaction AT vodetirajeshwar integratedqualitybydesignapproachfordevelopingnanolipidicdrugdeliverysystemsofolmesartanmedoxomilwithenhancedantihypertensiveaction AT shrivastavabirendra integratedqualitybydesignapproachfordevelopingnanolipidicdrugdeliverysystemsofolmesartanmedoxomilwithenhancedantihypertensiveaction AT bakshivasudha integratedqualitybydesignapproachfordevelopingnanolipidicdrugdeliverysystemsofolmesartanmedoxomilwithenhancedantihypertensiveaction |